In this Friday’s PCT Grand Rounds, Dr. John Spertus of the University of Missouri–Kansas City will present “The Next Generation of Patient-Centered Trials – No Site Visits, Home Delivery of Meds and Patient-Reported Outcomes – The CHIEF-HF Trial.” The Grand Rounds session will be held on Friday, February 25, at 1:00 pm eastern.
The CHIEF-HF trial examined the effect of canagliflozin on symptoms and quality of life for patients with heart failure. The trial was conducted completely remotely because of the COVID-19 pandemic and thus offers lessons about remote strategies in future clinical trials.